Structural and biological exploration of Phe3-Phe 4-modified endomorphin-2 peptidomimetics

ACS Medicinal Chemistry Letters

Volumn 4, Issue 8, 2013, Pages 795-799

  Lesma, Giordano ^a   Salvadori, Severo ^b   Airaghi, Francesco ^a   Murray, Thomas F ^c   Recca, Teresa ^a   Sacchetti, Alessandro ^d   Balboni, Gianfranco ^e   Silvani, Alessandra ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d POLITECNICO DI MILANO   (Italy)

^e UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

conformational analysis; docking studies; opioid receptors; Peptidomimetics; amino acids

Indexed keywords

ENDOMORPHIN 2; LIGAND; MU OPIATE RECEPTOR; PEPTIDOMIMETIC AGENT;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; HYBRID; MOLECULAR DOCKING; MOLECULAR DYNAMICS; NONHUMAN; PHARMACOPHORE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 84881435753     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml400189r     Document Type: Article

References (28)

1. Lord, J. A.; Waterfield, A. A.; Hughes, J.; Kosterlitz, H. W. Endogenous Opioid Peptides: Multiple Agonists and Receptors Nature 1977, 267, 495-499
2. Fichna, J.; Janecka, A.; Costentin, J.; Do Rego, J.-C. The Endomorphin System and Its Evolving Neurophysiological Role Pharmacol. Rev. 2007, 59, 88-123
3. Waldhoer, M.; Bartlett, S. E.; Whistler, J. L. Opioid Receptors Annu. Rev. Biochem. 2004, 73, 953-990
4. Leitgeb, B. Structural Investigation of Endomorphins by Experimental and Theoretical Methods: Hunting for the Bioactive Conformation Chem. Biodiversity 2007, 4, 2703-2724
5. Liu, X.; Wang, Y.; Xing, Y.; Yu, J.; Ji, H.; Kai, M.; Wang, Z.; Wang, D.; Zhang, Y.; Zhao, D.; Wang, R. Design, Synthesis, and Pharmacological Characterization of Novel Endomorphin-1 Analogues As Extremely Potent μ-Opioid Agonists J. Med. Chem. 2013, 56, 3102-3114
6. Leitgeb, B.; Tóth, G. Aromatic-Aromatic and Proline-Aromatic Interactions in Endomorphin-1 and Endomorphin-2 Eur. J. Med. Chem. 2005, 40, 674-686
7. Yu, Y.; Wang, C. L.; Cui, Y.; Fan, Y. Z.; Liu, J.; Shao, X.; Liu, H. M.; Wang, R. C-Terminal Amide to Alcohol Conversion Changes the Cardiovascular Effects of Endomorphins in Anesthetized Rats Peptides 2006, 27, 136-143
8. Keresztes, A.; Szucs, M.; Borics, A.; Kövér, K. E.; Forró, E.; Fülöp, F.; Tömböly, C.; Péter, A.; Páhi, A.; Fábián, G.; Murányi, M.; Tóth, G. New Endomorphin Analogues Containing Alicyclic β-Amino Acids: Influence on Bioactive Conformation and Pharmacological Profile J. Med. Chem. 2008, 51, 4270-4279
9. ZPhe) Residues J. Med. Chem. 2010, 53, 4550-4554
10. Gentilucci, L.; Tolomelli, A.; De Marco, R.; Spampinato, S.; Bedini, A.; Artali, R. The Inverse Type II β-Turn on d -Trp-Phe, a Pharmacophoric Motif for MOR Agonists ChemMedChem 2011, 6, 1640-1653
11. Mallareddy, J. R.; Borics, A.; Keresztes, A.; Kövér, K.; Tourwé, D.; Tóth, G. Design, Synthesis, Pharmacological Evaluation, and Structure-Activity Study of Novel Endomorphin Analogues with Multiple Structural Modifications J. Med. Chem. 2011, 54, 1462-1472
12. Mollica, A.; Pinnen, F.; Stefanucci, A.; Feliciani, F.; Campestre, C.; Mannina, L.; Sobolev, A. P.; Lucente, G.; Davis, P.; Lai, J.; Ma, S.-W.; Porreca, F.; Hruby, V. J. The cis -4-Amino- l -proline Residue As a Scaffold for the Synthesis of Cyclic and Linear Endomorphin-2 Analogues J. Med. Chem. 2012, 55, 3027-3035
13. Mollica, A.; Pinnen, F.; Stefanucci, A.; Mannina, L.; Sobolev, A. P.; Lucente, G.; Davis, P.; Lai, J.; Ma, S.-W.; Porreca, F.; Hruby, V. J. cis -4-Amino- l -proline Residue As a Scaffold for the Synthesis of Cyclic and Linear Endomorphin-2 Analogues: Part 2 J. Med. Chem. 2012, 55, 8477-8482
14. Lesma, G.; Salvadori, S.; Airaghi, F.; Bojnik, E.; Borsodi, A.; Recca, T.; Sacchetti, A.; Balboni, G.; Silvani, A. Synthesis, Pharmacological Evaluation and Conformational Investigation of Endomorphin-2 Hybrid Analogues Mol. Diversity 2013, 17, 19-31
15. 3-Peptides J. Med. Chem. 2013, 56, 3419-3423
16. Vasudev, P. G.; Chatterjee, S.; Shamala, N.; Balaram, P. Structural Chemistry of Peptides Containing Backbone Expanded Amino Acid Residues: Conformational Features of β, γ, and Hybrid Peptides Chem. Rev. 2011, 111, 657-687
17. Horne, W. S.; Gellman, S. H. Foldamers with Heterogeneous Backbones Acc. Chem. Res. 2008, 41, 1399-1408
18. Seebach, D.; Gardiner, J. β-Peptidic Peptidomimetics Acc. Chem. Res. 2008, 41, 1366-1375
19. Caputo, R.; Cassano, E.; Longobardo, L.; Palumbo, G. Synthesis of Enantiopure N- and C-Protected Homo-β-Amino Acids by Direct Homologation of α-Amino Acids Tetrahedron 1995, 51, 12337-12350
20. Lee, H.-S.; Park, J.-S.; Kim, B. M.; Gellman, S. H. Efficient Synthesis of Enantiomerically Pure β2-Amino Acids via Chiral Isoxazolidinones J. Org. Chem. 2003, 68, 1575-1578
21. Yamazaki, T.; Ro, S.; Goodman, M.; Chung, N. N.; Schiller, P. W. A Topochemical Approach to Explain Morphiceptin Bioactivity J. Med. Chem. 1993, 36, 708-719
22. Shao, X.; Gao, Y.; Zhu, C.; Liu, X.; Yao, J.; Cui, Y.; Wang, R. Conformational Analysis of Endomorphin-2 Analogs with Phenylalanine Mimics by NMR and Molecular Modeling Bioorg. Med. Chem. 2007, 15, 3539-3547
23. Albrizio, S.; Carotenuto, A.; Fattorusso, C.; Moroder, L.; Picone, D.; Temussi, P. A.; D'Ursi, A. Environmental Mimic of Receptor Interaction: Conformational Analysis of CCK-15 in Solution J. Med. Chem. 2002, 45, 762-769
24. Borics, A.; Toth, G. Structural Comparison of μ-Opioid Receptor Selective Peptides Confirmed Four Parameters of Bioactivity J. Mol. Graphics Modell. 2010, 28, 495-505
25. Wu, Y.-C.; Jaglinski, T.; Hsieh, J.-Y.; Chiu, J.-J.; Chiang, T.-Y.; Hwang, C.-C. Four-Component Pharmacophore Model for Endomorphins toward μ Opioid Receptor Subtypes J. Mol. Model. 2012, 18, 825-834
26. Leitgeb, B. Spatial Relationships between the Pharmacophores of Endomorphin-2: A Comparative Study of Stereoisomers Cent. Eur. J. Chem. 2012, 10, 1791-1798
27. Manglik, A.; Kruse, A. C.; Kobilka, T. S.; Thian, F. S.; Mathiesen, J. M.; Sunahara, R. K.; Pardo, L.; Weis, W. I.; Kobilka, B. K.; Granier, S. Crystal Structure of the μ-Opioid Receptor Bound to a Morphinan Antagonist Nature 2012, 485, 321-326
28. Mosberg, H. I.; Fowler, C. B. Development and Validation of Opioid Ligand-Receptor Interaction Models: The Structural Basis of mu vs. delta Selectivity J. Pept. Res. 2002, 60, 329-335